期刊文献+

鲍曼不动杆菌对氨基糖苷类药物耐药机制研究 被引量:7

Study on the molecular mechanism of aminoglycoside resistance to Acinetobacter baumannii
下载PDF
导出
摘要 目的研究对氨基糖苷类抗菌药物耐药的鲍曼不动杆菌分子流行病学特征和耐药机制。方法采用琼脂稀释法检测抗菌药物对鲍曼不动杆菌的最低抑菌浓度(MIC),采用肠杆菌科基因间重复一致性序列(ERIC)-聚合酶链反应(PCR)研究耐药菌株的分子流行病学特征,采用特异性PCR、序列分析和接合试验研究介导耐药的分子机制。结果临床分离菌株对包括氨基糖苷类抗菌药物在内的多种药物广泛耐药,同源性分析显示属于7个流行克隆型。所有分离菌株均扩增出介导氨基糖苷类抗菌药物耐药的修饰酶和药物"外排泵"基因,部分菌株扩增出甲基化酶基因。结论修饰酶和甲基化酶介导鲍曼不动杆菌临床分离株对氨基糖苷类药物耐药,药物"外排泵"参与介导耐药机制形成,垂直传播和通过耐药性质粒的水平传递可能是耐药菌株播散的主要方式。 Objective To investigate the molecular epidemiology and mechanism of aminoglycoside resistance to Acinetobacter baumannii isolates.Methods Agar-dilution was carried out to detect the minimum inhibitory concentration(MIC),and enterobacterial repetitive intergenic consensus(ERIC)-polymerase chain reaction(PCR) was performed to analyze the molecular epidemiology of aminoglycoside-resistance isolates.Specific PCR,DNA sequencing,conjugation experiments were carried to confirm the transmission mechanism.Results All the clinical isolates were resistant to most drugs including aminoglycosides,and ERIC-PCR showed the isolates belonged to 7 genotypes.Specific PCR and DNA sequencing revealed that all isolates encoded aminoglycoside-modifying enzyme genes,efflux pump gene and methylase gene.Conclusions Producing of aminoglycoside-modifying enzyme and methylase mainly contribute to reduce the susceptibility of aminoglycosides in Acinetobacter baumannii.Efflux pump overexpression may as a cofactor in high-level aminoglycoside resistance.Vertical transmission and plasmid-mediated horizontal transmission are probably the principal epidemical mechanisms.
出处 《检验医学》 CAS 2012年第8期619-623,共5页 Laboratory Medicine
关键词 鲍曼不动杆菌 氨基糖苷类 耐药性 接合试验 外排泵 Acinetobacter baumannii; Aminoglycoside; Drug resistance; Conjugation experiment; Efflux pump
  • 相关文献

参考文献15

  • 1Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically [S]. 20th ed. M7-AS, CLSI, 2010.
  • 2魏华,孙立国,朱晶,张晓君,朱晨光,赵立平,庞小燕.不同的DNA提取法对两种常见医院感染菌ERIC-PCR鉴定的影响研究[J].中华医院感染学杂志,2007,17(9):1044-1047. 被引量:16
  • 3Valdezate S, Vindel A, Echeita A, et al. Topoisomer- ase II and 1V quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility [ J ]. Anti- microb Agents Chemother, 2002, 46 ( 3 ) :665-671.
  • 4Peleg AY, Seifert H, Paterson DL. Acinetobacter bau- mannii: emergence of a successful pathogen [ J ] Clin Microbiol Rev, 2008, 21 (3): 538-582.
  • 5Zarrilli R, Giannouli M, Tomasone F, et al. Carba- penem resistance in Acinetobacter baumannii: the mo- lecular epidemic features of an emerging problem in health care facilities[ J]. J Infect Dev Ctries, 2009, 3 (5) :335-341.
  • 6Yu FY, Yao D, Pan JY, et al. High prevalence of plas- mid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teach- ing hospital[J]. BMC Infect Dis, 2010, 10:184.
  • 7Doi Y, Adams JM, Yamane K, et al. Identification of 16S rRNA methylase-producing Acinetobacter bauman- nii clinical strains in North America [ J ]. Antimicrob Agents Chemother, 2007, 51 ( 11 ) :4209-4210.
  • 8Yu YS, Zhou H, Yang Q, et al. Widespread occur- rence of aminoglycoside resistance due to ArmA methy- lase in imipenem-resistant Acinetobacter baumannii isolates in China[ J]. J Antimicrob Chemother, 2007, 60(2) _. 454455.
  • 9余方友,陈婵,杜卫良,李国安,张雪青,陈增强,陈坚,王良兴,朱涛,瞿涤.质粒介导16S rRNA甲基化酶肺炎克雷伯菌临床分离株的检测及分子流行病学研究[J].中华检验医学杂志,2009,32(3):268-273. 被引量:3
  • 10Higgins PG, Wisplinghoff H, Stefanik D, et al. Selectionof topoisomerase mutations and over-expression of adeB mRNA transcripts during an outbreak of Aciaetobacter baumannii[ J]. J Antimicrob Chemother, 2004, 54 (4) :821-823.

二级参考文献54

  • 1李锐.ERIC-PCR技术在致尿路感染大肠埃希菌基因分型中的应用[J].全科医学临床与教育,2005,3(4):241-241. 被引量:1
  • 2邵海枫,赵晓智,王卫萍,王锦娜,李珍大.肺炎克雷伯菌中质粒介导的AMPC酶及相关表型研究[J].中华检验医学杂志,2006,29(2):117-119. 被引量:12
  • 3周俊英,周新,付有荣,郭清莲.铜绿假单胞菌采用肠杆菌属重复基因间隔共有序列-PCR的分析[J].中华医院感染学杂志,2006,16(8):846-849. 被引量:8
  • 4LeeK, KimYA, JoonY et al. IncreasingprevalanceofVancomycin-ResistantEnterococci, andCefoxitin-, Imipenem-, and Fluoroquinolone-Resistant Gram-Negative Bacilli: A KONSAR study in 2002[J]. Yonsei Medical lounal, 2004,45 : 598.
  • 5Beceiro A, Dominguez L, Ribera Aet al. Molecttlar Characterization of the Gene Encoding a new AmpC β-Laclamase in a clinical strain of Acinetobacter Genomic Species 3 ( AG3 ) [ J ]. Antimicrobial Agents and Chemotherapy,2004, p. 1374.
  • 6Segal H, Nelson EC, Hisha BG. Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical Isolate[J]. Anfimicrobial Agents and Chemotherpy,2004,P.612.
  • 7Corvec S, Caroff S, Espaze E et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains[J]. Journal of Antimicrobial Chemotherapy, 2003,52: 629.
  • 8Chen CH, Young TG, Huang CC. Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with blaTEM-1, AmpC-type bla and integrase Ⅰ genotypes,2006,39:372.
  • 9Bou G and Jesus MB. Cloning, Nucleotide sequencing and Analysis of the Gene encoding and AmpC β-Lactamase in Acinetobacter batunanni [ J ]. Antimicrobial Agents and Chemotherapy. Feb,.2000, P:428.
  • 10Hujer KM,Hamza NS,Hujer AM et al.ldentification of a New Variant of the Acinetobacter baumannii Cephalosporinase, ADC-7 β-Lactamase: Defining a Unique Family of Clss C Enzymes [ J ]. Antimicrobial Agents And Chemotherapy, July, 2005, p : 2941.

共引文献29

同被引文献71

  • 1王艳丽,黄茂,梅亚宁,殷凯生.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270. 被引量:24
  • 2冯旰珠,张扬,姚堃,赵水娣.多重耐药鲍曼不动杆菌16S rRNA甲基化酶、氨基糖苷类修饰酶基因研究[J].中国感染与化疗杂志,2008,8(4):303-306. 被引量:9
  • 3Chen L, Wang W, Zhou R, et al. Characteristics of fecal and mucosa-associated microbiota inChinese patients with inflammatory bowel disease, Medicine ( Baltimore ) , 2014,93 ( 8 ) : e51.
  • 4Khoshkholgh- Sima B, Sardari S, Izadi Mobarakeh J, et al. Insilico metabolome target analysis towards panC-based antimycobactefial agent discovery. Iran J Pharm Res, 2015,14 (1) :203-214.
  • 5Kubota A,Goda T,Tsuru T, et al. Efficacy and safety of strong acid electrolyzed water for peritoneal lavage to prevent surgical site infection in patients with perforated appendicitis. Surgery Today, 2015,45 (7) :876-879.
  • 6Brisibe S F, Ordinioha B, Gbeneolol P K. The effect of hospital infection control policy on the prevalence of surgical site infection in a tertiary hospital in South-South Nigeria. Niger Med J, 2015,56 (3) :194-198.
  • 7Hermance M E, Thangamani S. Tick Saliva enhances powassan virus transmission to the host, influencing its dissemination and the course of disease. J Virol,2015,89 ( 15 ) :7852-7860.
  • 8Bailey K L, Kalil A C. Ventilator-associated pneumonia (yap) with multidrug resistant (MDR) pathogens: optimal treatment? Curr Infect Dis Rep ,2015,17 ( 8 ) :494.
  • 9Ortiz-Urquiza A, Keyhani NO. Stress response signaling and virulence :insights from entomopathogenie fungi. Curt Genet, 2015, 61(3) :251.
  • 10Itani K M. care bundles and prevention of surgical site infection in coloreetal surgery. JAMA ,2015,314 (3) :289-290.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部